IRIS
PRINCIPI, MARIABEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.071
AS - Asia 2.949
EU - Europa 1.995
SA - Sud America 846
AF - Africa 75
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.982
SG - Singapore 1.249
CN - Cina 747
BR - Brasile 726
SE - Svezia 439
HK - Hong Kong 437
RU - Federazione Russa 399
IT - Italia 271
DE - Germania 265
VN - Vietnam 228
GB - Regno Unito 167
FI - Finlandia 110
UA - Ucraina 72
FR - Francia 65
IN - India 57
BE - Belgio 53
AR - Argentina 50
ID - Indonesia 49
CA - Canada 41
BD - Bangladesh 38
PL - Polonia 31
ZA - Sudafrica 30
MX - Messico 27
IQ - Iraq 21
EC - Ecuador 19
TR - Turchia 19
ES - Italia 18
NL - Olanda 18
RO - Romania 18
IE - Irlanda 16
JP - Giappone 14
VE - Venezuela 14
CI - Costa d'Avorio 13
UZ - Uzbekistan 13
AT - Austria 11
CO - Colombia 11
PK - Pakistan 11
AU - Australia 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
DZ - Algeria 9
GT - Guatemala 9
PY - Paraguay 9
MA - Marocco 8
EG - Egitto 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
LB - Libano 6
PE - Perù 6
UY - Uruguay 6
AZ - Azerbaigian 5
EU - Europa 5
IL - Israele 5
KR - Corea 5
CL - Cile 4
MK - Macedonia 4
TH - Thailandia 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
GE - Georgia 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
PA - Panama 2
PH - Filippine 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 14.954
Salva come PNG Salva come JPEG
Città #
Fairfield 1.284
Woodbridge 918
Ashburn 902
Chandler 680
Singapore 602
Houston 596
Seattle 507
Cambridge 464
Hong Kong 436
Wilmington 421
Ann Arbor 420
Nyköping 361
Beijing 272
Dallas 221
Jacksonville 221
New York 153
Lawrence 132
Roxbury 130
Nanjing 125
Los Angeles 95
Des Moines 78
Bari 74
Ho Chi Minh City 73
Princeton 71
Inglewood 68
São Paulo 66
Brussels 52
Dearborn 52
Brooklyn 51
Boardman 50
San Diego 46
Santa Clara 44
Hanoi 39
Munich 37
Buffalo 35
Jakarta 35
Chicago 31
London 30
The Dalles 28
Warsaw 28
Shenyang 27
Dong Ket 26
Jiaxing 26
Tianjin 25
Columbus 24
Hebei 24
Nanchang 24
Helsinki 22
Rio de Janeiro 22
Atlanta 20
Changsha 19
Moscow 18
Paris 18
Belo Horizonte 16
Council Bluffs 16
Dublin 16
Boston 15
Brasília 15
Chennai 15
Frankfurt am Main 15
Johannesburg 15
Stockholm 15
Curitiba 14
Nuremberg 14
Abidjan 13
Denver 13
Montreal 13
Redwood City 13
Tokyo 13
Guangzhou 12
Porto Alegre 12
Pune 12
Rome 12
Dhaka 11
Falls Church 11
Mexico City 11
Poplar 11
Toronto 11
Zhengzhou 11
Haiphong 10
Milan 10
Tashkent 10
Ankara 9
Campinas 9
Guatemala City 9
Hefei 9
Jinan 9
Orem 9
San Francisco 9
Shanghai 9
Baghdad 8
Falkenstein 8
Ha Long 8
Hangzhou 8
Manchester 8
Mumbai 8
Quito 8
Salvador 8
Charlotte 7
Da Nang 7
Totale 10.748
Salva come PNG Salva come JPEG
Nome #
Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score 194
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 178
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 172
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 169
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 168
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 167
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 164
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 162
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 162
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 160
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 154
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 153
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation 151
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis 148
A mysterious case of gastroparesis: could the secret be found in a drink? 147
Estrogens, phytoestrogens and colorectal neoproliferative lesions 140
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 135
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 134
Endothelial function and cardiovascular risk in active inflammatory bowel diseases. 132
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 132
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture 131
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 130
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 128
Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study 125
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality? 124
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 121
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease 120
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 120
Oral Tacrolimus (FK-506) in Crohn' s disease complicated by fistulae of perineum 118
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 116
Alimentary disorders in young females with irritable bowel syndrome or ulcerative procto-sigmoiditis: A preliminary report. 115
Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study 115
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study 112
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 109
The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy 109
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 109
The association between cardiac and gastrointestinal disorders: causal or casual link? 108
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 108
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 106
Pattern of apoptosis in Crohn’s disease: a singular aspect? 105
Celiac disease and common variable immunodeficiency: a familial inheritance? 103
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 103
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 102
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 102
null 101
null 100
null 99
The cost of inflammatory bowel disease management matches with clinical course: A single outpatient centre analysis 98
Seronegative celiac disease: where is the specific setting? 96
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness 95
null 94
Liver fibrosis in primary intestinal lymphangiectasia: an undervalued topic 93
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 93
Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis. 92
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study 91
null 90
null 89
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 88
Histamine and histaminergic receptors in colorectal cancer: From basic science to evidence-based medicine 88
La gastrite cronica da Helicobacter Heilmannii: una nuova entità istopatologica. L’ infezione da Helicobacter pilori: aggiornamento continuo G Bianchi Porro, G Maconi, F Parente 87
null 86
null 86
Effect of Helicobacter Pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression 86
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes? 85
null 85
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 84
Lactobacillus reuteri strain combination in helicobacter pylori infection: A randomized, double-blind, placebo-controlled study 83
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 83
Probiotics and Helicobacter pylori 82
null 82
Appliance of immunohistochemical techniques in Helicobacter pylori infection. Immunohistochemistry and Helicobacter pylori 82
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data] 82
null 81
null 81
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 81
null 80
null 80
The puzzle of coccoid forms of helicobacter pylori: Beyond basic science 80
null 79
Mucosal expression of Basic Fibroblastic Growth Factor, Syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies 79
Immunosuppressant supplementation to infliximab in Crohn's disease with extraintestinal involvement: A benefit in the long term? 79
null 79
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 79
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 78
Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatment for Crohn disease: a case report 77
null 77
La qualità della vita dei pazienti affetti da infiammazione intestinale 76
Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? 76
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 76
Long-term tacrolimus: a promising therapeutic approach for Crohn’s disease 75
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 74
null 74
Differential immunohistochemical expression of Syndecan-1 and Tumor necrosis factor alpha in colonic mucosa of patients with Crohn’s disease 74
null 73
null 73
null 72
null 71
A case of severe transaminase elevation following a single ustekinumab dose with remission after drug withdrawal 71
null 70
null 70
Totale 10.496
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.074
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021981 0 0 0 0 0 111 139 212 92 227 84 116
2021/20221.029 101 44 37 37 54 101 27 55 61 90 166 256
2022/20231.688 241 235 124 140 154 239 23 184 261 12 47 28
2023/2024566 35 107 23 55 52 163 14 22 6 27 13 49
2024/20252.524 40 36 161 76 57 218 337 234 107 144 398 716
2025/20263.107 882 352 434 632 729 78 0 0 0 0 0 0
Totale 15.605